[1]李秉昊,刘蜻蜻.超声造影对肝脏占位性病变的诊断价值[J].大理大学学报,2019,4(8):63-66.
[2]王豪,邓雅琴,宋嫣,等.超声造影在肝内局灶性病变的诊断价值[J].肝脏,2018,23(11):1039-1041.
[3]庾先翠,焦霞琴,毕晓刚,等.超声造影对肝脏占位性病变良恶性诊断的临床意义[J].中国实用医刊,2018,45(16):87-89.
[4]陈艳, 岳千钧, 何嘉宾. 能谱增强CT与超声对肝硬化增生结节与小肝癌的诊断和鉴别[J]. 中国现代普通外科进展 2021,24(5):403-405.
[5]张宏春,耿喆. 增强CT扫描与超声造影对肝脏占位性病变的临床诊断价值比较[J].实用肝脏病杂志,2016,19(6):696-699.
[6]闫春晓,杨文义,谭莉霞,等.超声造影与增强CT在肝癌射频消融术随访中的应用比较[J].中国CT和MRI杂志,2020,18(9):117-119,130.
[7]栾云,许华宁,吴意赟,等.超声造影对提高乳腺肿块系统分类准确性的价值评估[J].东南国防医药,2018,20(5):511-514.
[8]时静祥,王毅军,经翔,等.超声造影与增强螺旋CT诊断肝细胞癌的对比研究[J].天津医药,2017,45(6):643-647.
[9]黄艳丽,吕校平,张炽敏.肝硬化背景下超声造影对肝内微小结节的诊断价值[J].医学研究生学报,2017,30(3):298-301.
[10]Garcovich M,Faccia M,Meloni F,et al.Contrast-enhanced ultrasound patterns of hepatocellular adenoma:an Italian muhicenter experience[J].J Ultrasound,2019,22(2):157-165.
[11]Jang HJ,Kim TK,Burns PN,et al.Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US:comparison with histologic differentiation[J].Radiology,2017,244(3):898-906.
[12]夏俊来,王岗,陈涛毫.增强CT和超声造影在肝硬化伴肝小结节样病灶鉴别诊断中的应用[J].中国CT和MRI杂志,2020,18(8):93-96.
[13]Elfattah MA,Aboelmagd M,Elahamouly M.Prognostic factors of hepatocellular carcinoma survival after radio frequency ablation:A US population-based study[J].United European Gastroenterol J,2017,5(2):227-235.
[14]高白,姚胜银,王嫦华,等.肝细胞癌患者超声造影及CT增强扫描诊断价值比较[J].中国CT和MRI杂志,2019,17(5):96-99.
[15]Barreiros AP,Piscaglia F,Dietrich CF.Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma(HCC):Comments on AASLD guidelines[J].J Hepatol,2021,57(4):930-932.
[16]陈刚,唐晓军,魏强,等.超声造影评价肝动脉化疗栓塞联合微波消融治疗中晚期肝癌疗效[J].东南国防医药,2016,18(5):531-533,539.